The Jak-Stat Pathway: Cytokine Signalling from the Receptor to the Nucleus

References

• Darnell J. E., Jr, Kerr I. M., Stark G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415–1421
   PubMed Web of Science ®Google Scholar
• Aguet M., Dembic Z., Merlin G. Molecular cloning and expression of the human interferon-gamma receptor. Cell 1988; 55: 273–280
   PubMed Web of Science ®Google Scholar
• Soh J., Donnelly R. J., Kotenko S., Mariano T. M., Cook J. R., Wang N., Emanuel S., Schwartz B., Miki T., Pestka S. Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell 1994; 76: 793–802
   PubMed Web of Science ®Google Scholar
• Hemmi S., Bohni R., Stark G., DiMarco F., Aguet M. A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells. Cell 1994; 76: 803–810
   PubMed Web of Science ®Google Scholar
• Igarashi K., Garotta G., Ozmen L., Ziemiecki A., Wilks A. F., Harpur A. G., Larner A. C., Finbloom D. S. Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. J. Biol. Chem. 1994; 269: 14333–14336
   PubMed Web of Science ®Google Scholar
• Kotenko S. V., Izotova L. S., Pollack B. P., Mariano T. M., Donnelly R. J., Mutukumaran G., Cook J. R., Garotta G., Silvennoinen O., Ihle J. N., Pestka S. Interaction Between the Components Of the Interferon Gamma Receptor Complex. J. Biol. Chem. 1995; 270: 20915–20921
   PubMed Web of Science ®Google Scholar
• Greenlund A. C., Farrar M. A., Viviano B. L., Schreiber R. D. Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transaction system (p91). EMBO J. 1994; 13: 1591–1600
   PubMed Web of Science ®Google Scholar
• Heim M. H., Kerr I. M., Stark G. R., Darnell J. E., Jr. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 1995; 267: 1347–1349
   PubMed Web of Science ®Google Scholar
• Shuai K., Stark G. R., Kerr I. M., Darnell J. E., Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 1993; 261: 1744–1746
   PubMed Web of Science ®Google Scholar
• Shuai K., Horvath C. M., Huang L. H., Qureshi S. A., Cowburn D., Darnell J. E., Jr. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 1994; 76: 821–828
   PubMed Web of Science ®Google Scholar
• Darnell J. E., Jr. STATs and Gene Regulation. Science 1997; 277: 1630–1635
   PubMed Web of Science ®Google Scholar
• Schindler C., Shuai K., Prezioso V. R., Darnell J. E., Jr. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 1992; 257: 809–813
   PubMed Web of Science ®Google Scholar
• Durbin J. E., Hackenmiller R., Simon M. C., Levy D. E. Targeted disruption of the mouse statl results in compromised innate immunity to viral disease. Cell 1996; 84: 443–450
   PubMed Web of Science ®Google Scholar
• Meraz M. A., White J. M., Sheehan K. C. F., Bach E. A., Rodig S. J., Dighe A. S., Kaplan D. H., Riley J. K., Greenlund A. C., Campbell D., Carvermoore K., Dubois R. N., Clark R., Aguet M., Schreiber R. D. Targeted disruption of the stal1 gene in mice reveals unexpected physiologic specificity in the jak-stat signaling pathway. Cell 1996; 84: 431–442
   PubMed Web of Science ®Google Scholar
• Silvennoinen O., Schindler C., Schlessinger J., Levy D. E. Rasindependent growth factor signaling by transcription factor tyrosine phosphorylation. Science 1993; 261: 1736–1739
   PubMed Web of Science ®Google Scholar
• Bacon C. M., Tortolani P. J., Shimosaka A., Rees R. C., Longo D. L., O'Shea J. J. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3. FEBS Lett. 1995; 370: 63–68
   PubMed Web of Science ®Google Scholar
• Raz R., Durbin J. E., Levy D. E. Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors. J. Biol. Chem. 1994; 269: 24391–24395
   PubMed Web of Science ®Google Scholar
• Yamamoto K., Quelle F. W., Thierfelder W. E., Kreider B. L., Gilbert D. J., Jenkins N. A., Copeland N. G., Silvennoinen O., Ihle J. N. Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol. Cell. Biol. 1994; 14: 4342–4349
   PubMed Web of Science ®Google Scholar
• Yu C. R., Lin J. X., Fink D. W., Akira S., Bloom E. T., Yamauchi A. Differential utilization of janus kinase-signal transducer and activator of transcription signaling pathways in the stimulation of human natural killer cells by il-2, il-12, and ifn-alpha. J. Immunol. 1996; 157: 126–137
   PubMed Web of Science ®Google Scholar
• Cho S. S., Bacon C. M., Sudarshan C., Rees R. C., Finbloom D., Pine R., Oshea J. J. Activation of stat4 by il-12 and ifn-alpha - evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 1996; 157: 4781–4789
   PubMed Web of Science ®Google Scholar
• Fasler-Kan E., Pansky A., Wiederkehr M., Battegay M., Heim M. H. IFN-a activates Stat5 and Stat6 in Daudi cells. Eur. J. Biochem. 1998, in press
   PubMedGoogle Scholar
• Meinke A., Barahmandpour F., Wohrl S., Stoiber D., Decker T. Activation of different stat5 isoforms contributes to cell-type restricted signaling in response to interferons. Mol. Cell. Biol. 1996; 16: 6937–6944
   PubMed Web of Science ®Google Scholar
• Shuai K., Schindler C., Prezioso V. R., Darnell J. E., Jr. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 1992; 258: 1808–1812
   PubMed Web of Science ®Google Scholar
• Heim M. H., Gamboni G., Beglinger C., Gyr K. Specific activation of AP-1 but not Stat3 in regenerating liver in mice. Eur. J. Clin. Invest 1997; 27: 948–955
   PubMed Web of Science ®Google Scholar
• Ruff-Jamison S., Chen K., Cohen S. Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science 1993; 261: 1733–1736
   PubMed Web of Science ®Google Scholar
• Larner A. C., David M., Feldman G. M., Igarashi K., Hackett R. H., Webb D. S., Sweitzer S. M., Petricoin E. D., Finbloom D. S. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 1993; 261: 1730–1733
   PubMed Web of Science ®Google Scholar
• Finbloom D. S., Winestock K. D. IL- 10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J. Immunol. 1995; 155: 1079–1090
   PubMed Web of Science ®Google Scholar
• Lai C. F., Ripperger J., Morella K. K., Jurlander J., Hawley T. S., Carson W. E., Kordula T., Caliguri M. A., Hawley R. G., Fey G. H., Baumann H. Receptors for interleukin (i1)-10 and il-6-type cytokines use similar signaling mechanisms for inducing transcription through il-6 response elements. J. Biol. Chem. 1996; 271: 13968–13975
   PubMed Web of Science ®Google Scholar
• Lutticken C., Wegenka U. M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A. G., Wilks A. F., Yasukaws K., Taga T., et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 1994; 263: 89–92
   PubMed Web of Science ®Google Scholar
• Akira S., Nishio Y., Inoue M., Wang X. J., Wei S., Matsusaka T., Yoshida K., Sudo T., Naruto M., Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994; 77: 63–71
   PubMed Web of Science ®Google Scholar
• Zhong Z., Wen Z., Darnell J. E., Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264: 95–98
   PubMed Web of Science ®Google Scholar
• Baumann H., Wang Y. P., Morella K. K., Lai C. F., Dams H., Hilton D. J., Hawley R. G., Mackiewicz A. Complex of the soluble il-11 receptor and il-11 acts as il-6-type cytokine in hepatic and nonhepatic cells. J. Immunol. 1996; 157: 284–290
   PubMed Web of Science ®Google Scholar
• Zhao Y., Nichols J. E., Bulun S. E., Mendelson C. R., Simpson E. R. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J. Biol. Chem. 1995; 270: 16449–16457
   PubMed Web of Science ®Google Scholar
• Levy J. B., Schindler C., Raz R., Levy D. E., Baron R., Horowitz M. C. Activation of the jak-stat signal transduction pathway by oncostatin-m in cultured human and mouse osteoblastic cells. Endocrinology 1996; 137: 1159–1165
   PubMed Web of Science ®Google Scholar
• Boulton T. G., Zhong Z., Wen Z., Darnell J. E., Jr., Stahl N., Yancopoulos G. D. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 1995; 92: 6915–6919
   PubMed Web of Science ®Google Scholar
• Auguste P., Guillet C., Fourcin M., Olivier C., Veziers J., Pouplard-Barthelaix A., Gascan H. Signaling of type II oncostatin M receptor. J. Biol. Chem. 1997; 272: 15760–15764
   PubMed Web of Science ®Google Scholar
• Campbell G. S., Meyer D. J., Raz R., Levy D. E., Schwartz J., Carter-Su C. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. J. Biol. Chem. 1995; 270: 3974–3979
   PubMedGoogle Scholar
• Bonni A., Frank D. A., Schindler C., Greenberg M. E. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus. Science 1993; 262: 1575–1579
   PubMed Web of Science ®Google Scholar
• Robledo O., Fourcin M., Chevalier S., Guillet C., Auguste P., Pouplard-Barthelaix A., Pennica D., Gascan H. Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component. J. Biol. Chem. 1997; 272: 4855–4863
   PubMed Web of Science ®Google Scholar
• Dekoning J. P., Dong F., Smith L., Schelen A. M., Barge R. M. Y., Vanderplas D. C., Hoefsloot L. H., Lowenberg B., Touw I. P. The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for stat3 but not stat1 homodimer formation. Blood 1996; 87: 1335–1342
   PubMed Web of Science ®Google Scholar
• Tian S. S., Tapley P., Sincich C., Stein R. B., Rosen J., Lamb P. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of jaks, stat5, and/or stat3 are required for regulation of three distinct classes of immediate early genes. Blood 1996; 88: 4435–4444
   PubMed Web of Science ®Google Scholar
• Shimoda K., Feng J., Murakami H., Nagata S., Watling D., Rogers N. C., Stark G. R., Kerr I. M., Ihle J. N. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 1997; 90: 597–604
   PubMed Web of Science ®Google Scholar
• Szabo S. J., Jacobson N. G., Dighe A. S., Gubler U., Murphy K. M. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995; 2: 665–675
   PubMed Web of Science ®Google Scholar
• Jacobson N. G., Szabo S. J., Weber-Nordt R. M., Zhong Z., Schreiber R. D., Darnell J. E., Jr., Murphy K. M. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 1995; 181: 1755–1762
   PubMed Web of Science ®Google Scholar
• Bacon C. M., Petricoin E. F., Ortaldo J. R., Rees R. C., Larner A. C., Johnston J. A., Oshea J. J. Interleukin 12 induces tyrosine phosphorylation and activation of Stat4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 1995; 92: 7307–7311
   PubMed Web of Science ®Google Scholar
• Klein J. L., Fickenscher H., Holliday J. E., Biesinger B., Fleckenstein B. Herpesvirus Saimiri Immortalized Gamma-Delta T Cell Line Activated By Il-12. J. Immunol. 1996; 156: 2754–2760
   PubMed Web of Science ®Google Scholar
• Kaplan M. H., Sun Y. L., Hoey T., Grusby M. J. Impaired Il-12 responses and enhanced development of Th2 cells in stat4-deficient mice. Nature 1996; 382: 174–177
   PubMed Web of Science ®Google Scholar
• Thierfelder W. E., Vandeursen J. M., Yamamoto K., Tripp R. A., Sarawar S. R., Carson R. T., Sangster M. Y., Vignali D. A. A., Doherty P. C., Grosveld G. C., Ihle J. N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996; 382: 171–174
   PubMed Web of Science ®Google Scholar
• Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M. H., Skoda R. C. Defective stat signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 1996; 93: 6231–6235
   PubMed Web of Science ®Google Scholar
• Baumann H., Morella K. K., White D. W., Dembski M., Bailon P. S., Kim H. K., Lai C. F., Tartaglia L. A. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA 1996; 93: 8374–8378
   PubMed Web of Science ®Google Scholar
• Vaisse C., Halaas J. L., Horvath C. M., Darnell J. E., Stoffel M., Friedman J. M. Leptin activation of Stat3 in the hypothalamus of wildtype and ob/ob mice but not db/db mice. Nat. Genet. 1996; 14: 95–97
   PubMed Web of Science ®Google Scholar
• Hou J., Schindler U., Henzel W. J., Wong S. C., McKnight S. L. Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 1995; 2: 321–329
   PubMed Web of Science ®Google Scholar
• Beadling C., Guschin D., Witthuhn B. A., Ziemiecki A., Ihle J. N., Kerr I. M., Cantrell D. A. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 1994; 13: 5605–5615
   PubMed Web of Science ®Google Scholar
• Lin J. X., Migone T. S., Tsang M., Friedmann M., Weatherbee J. A., Zhou L., Yamauchi A., Bloom E. T., Mietz J., John S. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995; 2: 331–339
   PubMed Web of Science ®Google Scholar
• Nielsen M., Svejgaard A., Skov S., Odum N. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur. J. Immunol. 1994; 24: 3082–3086
   PubMed Web of Science ®Google Scholar
• Johnston J. A., Bacon C. M., Finbloom D. S., Rees R. C., Kaplan D., Shibuya K., Ortaldo J. R., Gupta S., Chen Y. Q., Giri J. D., et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 1995; 92: 8705–8709
   PubMed Web of Science ®Google Scholar
• Quelle F. W., Shimoda K., Thierfelder W., Fischer C., Kim A., Ruben S. M., Cleveland J. L., Pierce J. H., Keegan A. D., Nelms K., et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 1995; 15: 3336–3343
   PubMed Web of Science ®Google Scholar
• Gilmour K. C., Pine R., Reich N. C. Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc. Natl. Acad. Sci. USA 1995; 92: 10772–10776
   PubMed Web of Science ®Google Scholar
• Nakajima H., Liu X. W., Wynshaw-Boris A., Rosenthal L. A., Imada K., Finbloom D. S., Hennighausen L., Leonard W. J. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 1997; 7: 691–701
   PubMed Web of Science ®Google Scholar
• Yin T., Keller S. R., Quelle F. W., Witthuhn B. A., Tsang M. L., Lienhard G. E., Ihle J. N., Yang Y. C. Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases. J. Biol. Chem. 1995; 270: 20497–20502
   PubMed Web of Science ®Google Scholar
• Hou J., Schindler U., Henzel W. J., Ho T. C., Brasseur M., McKnight S. L. An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994; 265: 1701–1706
   PubMed Web of Science ®Google Scholar
• Palmercrocker R. L., Hughes C. C. W., Pober J. S. Il-4 and Il-13 activate the Jak2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma(c) chain. J. Clin. Invest 1996; 98: 604–609
   PubMed Web of Science ®Google Scholar
• Kaplan M. H., Schindler U., Smiley S. T., Grusby M. J. Stat6 is required for mediating responses to Il-4 and for the development of Th2 cells. Immunity 1996; 4: 313–319
   PubMed Web of Science ®Google Scholar
• Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi K., Yoshida N., Kishimoto T., Akira S. Essential role of Stat6 in Il-4 signalling. Nature 1996; 380: 627–630
   PubMed Web of Science ®Google Scholar
• Shimoda K., Vandeursen J., Sangster M. Y., Sarawar S. R., Carson R. T., Tripp R. A., Chu C., Quelle F. W., Nosaka T., Vignali D. A. A., Doherty P. C., Grosveld G., Paul W. E., Ihle J. N. Lack of Il-4-induced Th2 response and ige class switching in mice with disrupted Stat6 gene. Nature 1996; 380: 630–633
   PubMed Web of Science ®Google Scholar
• Demoulin J. B., Uyttenhove C., Vanroost E., Delestre B., Donckers D., Vansnick J., Renauld J. C. A single tyrosine of the interleukin-9 (Il-9) receptor is required for Stat activation, antiapoptotic activity, and growth regulation by Il-9. Mol. Cell. Biol. 1996; 16: 4710–4716
   PubMed Web of Science ®Google Scholar
• Tagaya Y., Burton J. D., Miyamoto Y., Waldmann T. A. Identification of a novel receptor signal transduction pathway for Il-15/T in mast cells. EMBO J. 1996; 15: 4928–4939
   PubMed Web of Science ®Google Scholar
• Murata T., Noguchi P. D., Puri R. K. Il-13 induces phosphorylation and activation of Jak2 janus kinase in human colon carcinoma cell lines - similarities between Il-4 and Il-13 signaling. J. Immunol. 1996; 156: 2972–2978
   PubMed Web of Science ®Google Scholar
• Malabarba M. G., Rui H., Deutsch H. H. J., Chung J., Kalthoff F. S., Farrar W. L., Kirken R. A. Interleukin-13 is a potent activator of jak3 and stat6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha. Biochem. J. 1996; 319: 865–872
   PubMed Web of Science ®Google Scholar
• Takeda K., Kamanaka M., Tanaka T., Kishimoto T., Akira S. Impaired Il-13-mcdiated functions of macrophages in stat6-deficient mice. J. Immunol. 1996; 157: 3220–3222
   PubMed Web of Science ®Google Scholar
• Azam M., Erdjument-Bromage H., Kreider B. L., Xia M., Quelle F., Basu R., Saris C., Tempst P., Ihle J. N., Schindler C. Interleukin-3 signals through multiple isoforms of Stat5. EMBO J. 1995; 14: 1402–1411
   PubMed Web of Science ®Google Scholar
• Mui A. L., Wakao H. M. O. F. A., Harada N., Miyajima A. Interleukin 3, granulocyte macrophage colony stimulating factor and interleukin 5 transduce signals through two STAT5 homologs. EMBO J. 1995; 14: 1166–1175
   PubMed Web of Science ®Google Scholar
• Heim M. H. 1998, unpublished observation
   Google Scholar
• van Caldenhoven E. D. T., Raaijmakers J. A., Lammers J. W., Koenderman L., De G. R. P. Activation of the STAT3/acute phase response factor transcription factor by interleukin-5. J. Biol. Chem. 1995; 270: 25778–25784
   PubMedGoogle Scholar
• Gouilleux F., Pallard C., Dusanter-Fourt I., Wakao H., Haldosen L. A., Norstedt G., Levy D., Groner B. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 1995; 14: 2005–2013
   PubMed Web of Science ®Google Scholar
• Rosen R. L., Winestock K. D., Chen G., Liu X. W., Hennighausen L., Finbloom D. S. Granulocyte-Macrophage Colony-Stimulating Factor Preferentially Activates the 94-Kd Stat5a and an 80-Kd Stat5a Isoform In Human Peripheral Blood Monocytes. Blood 1996; 88: 1206–1214
   PubMed Web of Science ®Google Scholar
• Penta K., Sawyer S. T. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. J. Biol. Chem. 1995; 270: 31282–31287
   PubMed Web of Science ®Google Scholar
• Quelle F. W., Wang D., Nosaka T., Thierfelder W. E., Stravopodis D., Weinstein Y., Ihle J. N. erythropoietin induces activation of stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 1996; 16: 1622–1631
   PubMed Web of Science ®Google Scholar
• Miyakawa Y., Oda A., Druker B. J., Miyazaki H., Handa M., Ohashi H., Ikeda Y. Thrombopoietin induces tyrosine phosphorylation of stat3 and stat5 in human blood platelets. Blood 1996; 87: 439–446
   PubMed Web of Science ®Google Scholar
• Ram P. A., Park S. H., Choi H. K., Waxman D. J. Growth hormone activation of stat 1, slat 3, and stat 5 in rat liver - differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J. Biol. Chem. 1996; 271: 5929–5940
   PubMed Web of Science ®Google Scholar
• Udy G. B., Towers R. P., Snell R. G., Wilkins R. J., Park S. H., Ram P. A., Waxman D. J., Davey H. W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 1997; 94: 7239–7244
   PubMed Web of Science ®Google Scholar
• Wakao H., Gouilleux F., Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 1994; 13: 2182–2191
   PubMed Web of Science ®Google Scholar
• Liu X. W., Robinson G. W., Wagner K. U., Garrett L., Wynshawboris A., Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997; 11: 179–186
   PubMed Web of Science ®Google Scholar
• Drachman J. G., Sabath D. F., Fox N. E., Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 1997; 89: 483–492
   PubMed Web of Science ®Google Scholar
• Matsumura I., Ishikawa J., Nakajima K., Oritani K., Tomiyama Y., Miyagawa J., Kato T., Miyazaki H., Matsuzawa Y., Kanakura Y. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAFl/Cip1) by STAT5. Mol. Cell. Biol. 1997; 17: 2933–2943
   PubMed Web of Science ®Google Scholar
• Sattler M., Durstin M. A., Frank D. A., Okuda K., Kaushansky K., Salgia R., Griffin J. D. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp. Hematol. 1995; 23: 1040–1048
   PubMed Web of Science ®Google Scholar
• Brizzi M. F., Battaglia E., Rosso A., Strippoli P., Montrucchio G., Camussi G., Pegoraro L. Regulation of polymorphonuclear cell activation by thrombopoietin. J. Clin. Invest 1997; 99: 1576–1584
   PubMed Web of Science ®Google Scholar
• Pallard C., Gouilleux F., Benit L., Cocault L., Souyri M., Levy D., Groner B., Gisselbrecht S., Dusanter-Fourt I. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J. 1995; 14: 2847–2856
   PubMed Web of Science ®Google Scholar
• Sadowski H. B., Shuai K., Darnell J. E., Jr., Gilman M. Z. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 1993; 261: 1739–1744
   PubMed Web of Science ®Google Scholar
• Chin Y. E., Kitagawa M., Su W. C. S., You Z. H., Iwamoto Y., Fu X. Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21(waf1/cip1) mediated by Stat1. Science 1996; 272: 719–722
   PubMed Web of Science ®Google Scholar
• Shuai K., Ziemiecki A., Wilks A. F., Harpur A. G., Sadowski H. B., Gilman M. Z., Darnell J. E., Jr. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 1993; 366: 580–583
   PubMed Web of Science ®Google Scholar
• Mellitzer G., Wessely O., Decker T., Meinke A., Hayman M. J., Beug H. Activation of stat 5b in erythroid progenitors correlates with the ability of erbb to induce sustained cell proliferation. Proc. Natl. Acad. Sci. USA 1996; 93: 9600–9605
   PubMed Web of Science ®Google Scholar
• Ruff-Jamison S., Zhong Z., Wen Z., Chen K., Darnell J. E., Jr., Cohen S. Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver. J. Biol. Chem. 1994; 269: 21933–21935
   PubMed Web of Science ®Google Scholar
• Ruff-Jamison S., Chen K., Cohen S. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat5 in mouse liver. Proc. Natl. Acad. Sci. USA 1995; 92: 4215–4218
   PubMed Web of Science ®Google Scholar
• Novak U., Harpur A. G., Paradiso L., Kanagasundaram V., Jaworowski A., Wilks A. F., Hamilton J. A. Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts. Blood 1995; 86: 2948–2956
   PubMed Web of Science ®Google Scholar
• Vignais M. L., Sadowski H. B., Watling D., Rogers N. C., Gilman M. Platelet-derived growth factor induces phosphorylation of multiple jak family kinases and stat proteins. Mol. Cell. Biol. 1996; 16: 1759–1769
   PubMed Web of Science ®Google Scholar
• Novak U., Mui A., Miyajima A., Paradiso L. Formation of stat5-containing dna binding complexes in response to colony-stimulating factor-1 and platelet-derived growth factor. J. Biol. Chem. 1996; 271: 18350–18354
   PubMed Web of Science ®Google Scholar
• Patel B. K. R., Wang L. M., Lee C. C., Taylor W. G., Pierce J. H., Larochelle W. J. Stat6 and jak1 are common elements in platelet-derived growth factor and interleukin-4 signal transduction pathways in nih 3t3 fibroblasts. J. Biol. Chem. 1996; 271: 22175–22182
   PubMed Web of Science ®Google Scholar
• Megeney L. A., Perry R. L. S., Lecouter J. E., Rudnicki M. A. Bfgf and Lif signaling activates stat3 in proliferating myoblasts. Developmental Genetics 1996; 19: 139–145
   PubMedGoogle Scholar
• Deberry C., Mou S., Linnekin D. Stat1 associates with c-kit and is activated in response to stem cell factor. Biochem. J. 1997; 327: 73–80
   PubMed Web of Science ®Google Scholar
• Chen J., Sadowski H. B., Kohanski R. A., Wang L. H. Stat5 is a physiological substrate of the insulin receptor. Proc. Natl. Acad. Sci. USA 1997; 94: 2295–2300
   PubMed Web of Science ®Google Scholar
• Boccaccio C., Ando M., Tamagnone L., Bardelli A., Michieli P., Battistini C., Comoglio P. M. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 1998; 391: 285–288
   PubMed Web of Science ®Google Scholar
• Marrero M. B., Schieffer B., Paxton W. G., Heerdt L., Berk B. C., Delafontaine P., Bernstein K. E. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995; 375: 247–250
   PubMed Web of Science ®Google Scholar
• Bhat G. J., Thekkumkara T. J., Thomas W. G., Conrad K. M., Baker K. M. Activation of the stat pathway by angiotensin ii in t3cho/at(1a) cells - cross-talk between angiotensin ii and interleukin-6 nuclear signaling. J. Biol. Chem. 1995; 270: 19059–19065
   PubMed Web of Science ®Google Scholar
• Guillet-Deniau I., Burnol A. F., Girard J. Identification and localization of a skeletal muscle secrotonin 5-HT2A receptor coupled to the Jak/STAT pathway. J. Biol. Chem. 1997; 272: 14825–14829
   PubMed Web of Science ®Google Scholar
• Bhat G. J., Abraham S. T., Singer H. A., Baker K. M. Alpha-thrombin stimulates sis-inducing factor-A DNA binding activity in rat aortic smooth muscle cells. Hypertension 1997; 29: 356–360
   PubMed Web of Science ®Google Scholar
• Karras J. G., Wang Z. H., Coniglio S. J., Frank D. A., Rothstein T. L. Antigen-receptor engagement in b cells induces nuclear expression of stat5 and stat6 proteins that bind and transactivate an ifn-gamma activation site. J. Immunol. 1996; 157: 39–47
   PubMed Web of Science ®Google Scholar
• Karras J. G., Wang Z., Huo L., Frank D. A., Rothstein T. L. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement. J. Immunol. 1997; 159: 4350–4355
   PubMed Web of Science ®Google Scholar
• Leaman D. W., Pisharody S., Flickinger T. W., Commane M. A., Schlessinger J., Kerr I. M., Levy D. E., Stark G. R. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol. Cell. Biol. 1996; 16: 369–375
   PubMed Web of Science ®Google Scholar
• David M., Wong L., Flavell R., Thompson S. A., Wells A., Larner A. C., Johnson G. R. Stat activation by epidermal growth factor (egf) and amphiregulin - requirement for the egf receptor kinase but not for tyrosine phosphorylation sites or jak1. J. Biol. Chem. 1996; 271: 9185–9188
   PubMed Web of Science ®Google Scholar
• Coffer P. J., Kruijer W. Egf receptor deletions define a region specifically mediating stat transcription factor activation. Biochem. Bioph. Res. Co. 1995; 210: 74–81
   PubMed Web of Science ®Google Scholar
• Valgeirsdottir S., Paukku K., Silvennoinen O., Heldin C. H., Claesson-Welsh L. Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains. Oncogene 1998; 16: 505–515
   PubMed Web of Science ®Google Scholar
• Novak U., Nice E., Hamilton J. A., Paradiso L. Requirement for Y706 of the murine (or Y708 of the human) csf-1 receptor for stat1 activation in response to csf-1. Oncogene 1996; 13: 2607–2613
   PubMed Web of Science ®Google Scholar
• Sawka-Verhelle D., Filloux C., Tartare-Deckert S., Mothe I., Van Obberghen E. Identification of Stat 5B as a substrate of the insulin receptor. Eur. J. Biochem. 1997; 250: 411–417
   PubMedGoogle Scholar
• Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 1990; 87: 6934–6938
   PubMed Web of Science ®Google Scholar
• Tanaguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 1995; 268: 251–255
   PubMed Web of Science ®Google Scholar
• Cosman D. The hematopoietin receptor superfamily. Cytokine 1993; 5: 95–106
   PubMed Web of Science ®Google Scholar
• Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell 1994; 76: 253–262
   PubMed Web of Science ®Google Scholar
• Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 1988; 241: 825–828
   PubMed Web of Science ®Google Scholar
• Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993; 260: 1808–1810
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Thut C. J., VandeBos T., Gimpel S. D., Delaney P. B., King J., Price V., Cosman D., Beckmann M. P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 1991; 10: 2839–2848
   PubMed Web of Science ®Google Scholar
• Pennica D., Shaw K. J., Swanson T. A., Moore M. W., Shelton D. L., Zioncheck K. A., Rosenthal A., Taga T., Paoni N. F., Wood W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 1995; 270: 10915–10922
   PubMed Web of Science ®Google Scholar
• Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L. S., Cosman D. Dual Oncostatin M (OSM) Receptors. Cloning and characterization of an alternative signaling subunit conferring osm-specific receptor activation. J. Biol. Chem. 1996; 271: 32635–32643
   PubMed Web of Science ®Google Scholar
• Davis S., Aldrich T. H., Valenzuela D. M., Wong V. V., Furth M. E., Squinto S. P., Yancopoulos G. D. The receptor for ciliary neurotrophic factor. Science 1991; 253: 59–63
   PubMed Web of Science ®Google Scholar
• Davis S., Aldrich T. H., Stahl N., Pan L., Taga T., Kishimoto T., Ip N. Y., Yancopoulos G. D. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 1993; 260: 1805–1808
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Hilton A. A., Raicevic A., Rakar S., Harrison-Smith M., Gough N. M., Begley C. G., Metcalf D., Nicola N. A., Willson T. A. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 1994; 13: 4765–4775
   PubMed Web of Science ®Google Scholar
• Yin T., Taga T., Tsang M. L., Yasukawa K., Kishimoto T., Yang Y. C. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J. Immunol. 1993; 151: 2555–2561
   PubMed Web of Science ®Google Scholar
• Chua A. O., Chizzonite R., Desai B. B., Truitt T. P., Nunes P., Minetti L. J., Warrier R. R., Presky D. H., Levine J. F., Gately M. K. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 1994; 153: 128–136
   PubMed Web of Science ®Google Scholar
• Fukunaga R., Ishizaka-Ikeda E., Seto Y., Nagata S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 1990; 61: 341–350
   PubMed Web of Science ®Google Scholar
• Tartaglia L. A., Dembski M., Weng X., Deng N. H., Culpepper J., Devos R., Richards G. J., Campfield L. A., Clark F. T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K. J., Smutko J. S., Mays G. G., Woolf E. A., Monroe C. A., Tepper R. I. Identification and expression cloning of a leptin receptor, Ob-R. Cell 1995; 83: 1263–1271
   PubMed Web of Science ®Google Scholar
• Stahl N., Farruggella T. J., Boulton T. G., Zhong Z., Darnell J. E., Jr., Yancopoulos G. D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995; 267: 1349–1353
   PubMed Web of Science ®Google Scholar
• Nicholson S. E., Novak U., Ziegler S. F., Layton L. E. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules jak2, stat3, and p42, p44(mapk). Blood 1995; 86: 3698–3704
   PubMed Web of Science ®Google Scholar
• Presky D. H., Yang H., Minetti L. J., Chua A. O., Nabavi N., Wu C. Y., Gately M. K., Gubler U. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 1996; 93: 14002–14007
   PubMed Web of Science ®Google Scholar
• Hatakeyama M., Tsudo M., Minamoto S., Kono T., Doi T., Miyata T., Miyasaka M., Tanaguchi T. Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta cDNA's. Science 1989; 244: 551–556
   PubMed Web of Science ®Google Scholar
• Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the gamma chain of the human IL-2 receptor. Science 1992; 257: 379–382
   PubMed Web of Science ®Google Scholar
• Giri J. G., Kumaki S., Ahdieh M., Friend D. J., Loomis A., Shanebeck K., DuBose R., Cosman D., Park L. S., Anderson D. M. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 1995; 14: 3654–3663
   PubMed Web of Science ®Google Scholar
• Anderson D. M., Kumaki S., Ahdieh M., Bertles J., Tometsko M., Loomis A., Giri J., Copeland N. G., Gilbert D. J., Jenkins N. A., et al. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 1995; 270: 29862–29869
   PubMed Web of Science ®Google Scholar
• Giri J. G., Ahdieh M., Eisenmann J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L. S., Cosman D., Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994; 13: 2822–2830
   PubMed Web of Science ®Google Scholar
• Kondo M., Takeshita T., Higuchi M., Nakamura M., Sudo T., Nishikawa S.-I., Sugamura K. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 1994; 263: 1453–1454
   PubMed Web of Science ®Google Scholar
• Miyazaki T., Kawahara A., Fujii H., Nakagawa Y., Minami Y., Liu Z. J., Oishi I., Silvennoinen O., Witthuhn B. A., Ihle J. N. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994; 266: 1045–1047
   PubMed Web of Science ®Google Scholar
• Russell S. M., Johnston J. A., Noguchi M., Kawamura M., Bacon C. M., Friedmann M., Berg M., McVicar D. W., Witthuhn B. A., Silvennoinen O. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 1994; 266: 1042–1045
   PubMed Web of Science ®Google Scholar
• Boussiotis V. A., Barber D. L., Nakarai T., Freeman G. J., Gribben J. G., Bernstein G. M., D'Andrea A. D., Ritz J., Nadler L. M. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science 1994; 266: 1039–1042
   PubMed Web of Science ®Google Scholar
• Aman M. J., Tayebi N., Obiri N. I., Puri R. K., Modi W. S., Leonard W. J. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J. Biol. Chem. 1996; 271: 29265–29270
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Zhang J. G., Metcalf D., Alexander W. S., Nicola N. A., Willson T. A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 1996; 93: 497–501
   PubMed Web of Science ®Google Scholar
• Fujiwara H., Hanissian S. H., Tsytsykova A., Geha R. S. Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA 1997; 94: 5866–5871
   PubMed Web of Science ®Google Scholar
• Russell S. M., Tayebi N., Nakajima H., Riedy M. C., Roberts J. L., Aman M. J., Migone T. S., Noguchi M., Markert M. L., Buckley R. H., Oshea J. J., Leonard W. J. Mutation of jak3 in a patient with scid - essential role of jak3 in lymphoid development. Science 1995; 270: 797–800
   PubMed Web of Science ®Google Scholar
• Murata T., Noguchi P. D., Puri R. K. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J. Biol. Chem. 1995; 270: 30829–30836
   PubMed Web of Science ®Google Scholar
• Friedman M. C., Migone T. S., Russell S. M., Leonard W. J. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 1996; 93: 2077–2082
   PubMed Web of Science ®Google Scholar
• Gaffen S. L., Lai S. Y., Xu W. D., Gouilleux F., Groner B., Goldsmith M. A., Greene W. C. Signaling through the interleukin 2 receptor beta chain activates a stat-5-like dna-binding activity. Proc. Natl. Acad. Sci. US A 1995; 92: 7192–7196
   PubMed Web of Science ®Google Scholar
• Gaffen S. L., Lai S. Y., Ha M., Liu X. W., Henninghausen L., Greene W. C., Goldsmith M. A. Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity. J. Biol. Chem. 1996; 271: 21381–21390
   PubMed Web of Science ®Google Scholar
• Itoh N., Yonehara S., Schreurs J., Gorman D. M., Maruyama K., Ishii A., Yahara I., Arai K., Miyajima A. Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family. Science 1990; 247: 324–327
   PubMed Web of Science ®Google Scholar
• Murata Y., Takaki S., Migita M., Kikuchi Y., Tominaga A., Takatsu K. Molecular cloning and expression of the human interleukin 5 receptor. J. Exp. Med. 1992; 175: 341–351
   PubMed Web of Science ®Google Scholar
• Gearing D. P., King J. A., Gough N. M., Nicola N. A. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 1989; 8: 3667–3676
   PubMed Web of Science ®Google Scholar
• Hayashida K., Kitamura T., Gorman D. M., Arai K., Yokota T., Miyajima A. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc. Natl. Acad. Sci. USA 1990; 87: 9655–9659
   PubMed Web of Science ®Google Scholar
• van Dijk T. B., Caldenhoven E., Raaijmakers J. A., Lammers J. W., Koenderman L., de Groot R. P. Multiple tyrosine residues in the intracellular domain of the common beta subunit of the interleukin 5 receptor are involved in activation of STAT5. FEES Lett. 1997; 412: 161–164
   PubMed Web of Science ®Google Scholar
• Hansen L. H., Wang X. Z., Kopchick J. J., Bouchelouche P., Nielsen J. H., Galsgaard E. D., Billestrup N. Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and stat5 activation. J. Biol. Chem. 1996; 271: 12669–12673
   PubMed Web of Science ®Google Scholar
• Klingmuller U., Bergelson S., Hsiao J. G., Lodish H. F. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of stat5. Proc. Natl. Acad. Sci. USA 1996; 93: 8324–8328
   PubMed Web of Science ®Google Scholar
• Uze G., Lutfalla G., Gresser I. Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 1990; 60: 225–234
   PubMed Web of Science ®Google Scholar
• Novick D., Cohen B., Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 1994; 77: 391–400
   PubMed Web of Science ®Google Scholar
• Lutfalla G., Holland S. J., Cinato E., Monneron D., Reboul J., Rogers N. C., Smith J. M., Stark G. R., Gardiner K., Mogensen K. E. Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 1995; 14: 5100–5108
   PubMed Web of Science ®Google Scholar
• Colamonici O. R., Uyttendaele H., Domanski P., Yan H., Krolewski J. J. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J. Biol. Chem. 1994; 269: 3518–3522
   PubMed Web of Science ®Google Scholar
• Abramovich C., Shulman L. M., Ratovitski E., Harroch S., Tovey M., Eid P., Revel M. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta. EMBO J. 1994; 13: 5871–5877
   PubMed Web of Science ®Google Scholar
• Domanski P., Fish E., Nadeau O. W., Witte M., Platanias L. C., Yan H., Krolewski J., Pitha P., Colamonici O. R. A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak- Stat pathway and induce an antiviral state. J. Biol. Chem. 1997; 272: 26388–26393
   PubMed Web of Science ®Google Scholar
• Liu Y., Wei S. H., Ho A. S., de Waal Malefyt R., Moore K. W. Expression cloning and characterization of a human IL 10 receptor. J. Immunol. 1994; 152: 1821–1829
   PubMed Web of Science ®Google Scholar
• Lutfalla G., Gardiner K., Uze G. A new member of the cytokine receptor gene family maps on chromosome 21 at less than 35 kb from IFNAR. Genomics 1993; 16: 366–373
   PubMed Web of Science ®Google Scholar
• Kotenko S. V., Izotova L. S., Pollack B. P., Muthukumaran G., Paukku K., Silvennoinen O., Ihle J. N., Pestka S. Other kinases can substitute for jak2 in signal transduction by interferon-gamma. J. Biol. Chem. 1996; 271: 17174–17182
   PubMed Web of Science ®Google Scholar
• Muller M., Briscoe J., Laxton C., Guschin D., Ziemiecki A., Silvennoinen O., Harpur A. G., Barbieri G., Witthuhn B. A., Schindler C. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 1993; 366: 129–135
   PubMed Web of Science ®Google Scholar
• Watling D., Guschin D., Muller M., Silvennoinen O., Witthuhn B. A., Quelle F. W., Rogers N. C., Schindler C., Stark G. R., Ihle J. N. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 1993; 366: 166–170
   PubMed Web of Science ®Google Scholar
• Velazquez L., Fellous M., Stark G. R., Pellegrini S. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 1992; 70: 313–322
   PubMed Web of Science ®Google Scholar
• Yan H., Krishnan K., Greenlund A. C., Gupta S., Lim J. T. E., Schreiber R. D., Schindler C. W., Krolewski J. J. Phosphorylated interferon-alpha receptor 1 subunit (ifnar1) acts as a docking site for the latent form of the 113 kda stat2 protein. EMBO J. 1996; 15: 1064–1074
   PubMed Web of Science ®Google Scholar
• Li X., Leung S., Kerr I. M., Stark G. R. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol. Cell. Biol. 1997; 17: 2048–2056
   PubMed Web of Science ®Google Scholar
• Webernordt R. M., Riley J. K., Greenlund A. C., Moore K. W., Darnell J. E., Schreiber B. D. Stat-3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J. Biol. Chem. 1996; 271: 27954–27961
   PubMed Web of Science ®Google Scholar
• Heim M. H., Unpublished observation
   Google Scholar
• Feng J., Witthuhn B. A., Matsuda T., Kohlhuber F., Kerr I. M., Ihle J. N. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 1997; 17: 2497–2501
   PubMed Web of Science ®Google Scholar
• Luo H., Rose P., Barber D., Hanratty W. P., Lee S., Roberts T. M., D'Andrea A. D., Dearolf C. R. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol. Cell. Biol. 1997; 17: 1562–1571
   PubMed Web of Science ®Google Scholar
• Gauzzi M. C., Barbieri G., Richter M. F., Uze G., Ling L., Fellous M., Pellegrini S. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. Proc. Natl. Acad. Sci, USA 1997; 94: 11839–11844
   PubMed Web of Science ®Google Scholar
• Chen M., Cheng A., Chen Y. Q., Hymel A., Hanson E. P., Kimmel L., Minami Y., Taniguchi T., Changelian P. S., O'Shea J. J. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl. Acad. Sci. USA 1997; 94: 6910–6915
   PubMed Web of Science ®Google Scholar
• van Nosaka T. D. J. M., Tripp R. A., Thierfelder W. E., Witthuhn B. A., McMickle A. P., Doherty P. C., Grosveld G. C., Ihle J. N. Defective lymphoid development in mice lacking Jak3. Science 1995; 270: 800–802
   PubMed Web of Science ®Google Scholar
• Thomis D. C., Gurniak C. B., Tivol E., Sharpe A. H., Berg L. J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 1995; 270: 794–797
   PubMed Web of Science ®Google Scholar
• Candotti F., Oakes S. A., Johnston J. A., Giliani S., Schumacher R. F., Mella P., Fiorini M., Ugazio A. G., Badolato R., Notarangelo L. D., Bozzi F., Macchi P., Strina D., Vezzoni P., Blaese R. M., O'Shea J. J., Villa A. Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood 1997; 90: 3996–4003
   PubMed Web of Science ®Google Scholar
• Macchi P., Villa A., Giliani S., Sacco M. G., Frattini A., Porta F., Ugazio A. G., Johnston J. A., Candotti F., Oshea J. J., Vezzoni P., Notarangelo L. D. Mutations of jak-3 gene in patients with autosomal severe combined immune deficiency (scid). Nature 1995; 377: 65–68
   PubMed Web of Science ®Google Scholar
• Copeland N. G., Gilbert D. J., Schindler C., Zhong Z., Wen Z., Darnell J. E., Mui A. L. F., Miyajima A., Quelle F. W., Ihle J. N., Jenkins N. A. Distribution of the mammalian stat gene family in mouse chromosomes. Genomics 1995; 29: 225–228
   PubMed Web of Science ®Google Scholar
• Vinkemeier U., Cohen S. L., Moarefi I., Chait B. T., Kuriyan J., Darnell J. E. Dna binding of in vitro activated stat1-alpha, stat1-beta and truncated stat1 - interaction between nh2-terminal domains stabilizes binding of two dimers to tandem dna sites. EMBO J. 1996; 15: 5616–5626
   PubMed Web of Science ®Google Scholar
• Vinkemeier U., Moarefi I., Darnell J. E., Jr., Kuriyan J. Structure of the amino-terminal protein interaction domain of STAT-4. Science 1998; 279: 1048–1052
   PubMed Web of Science ®Google Scholar
• Guyer N. B., Severns C. W., Wong P., Feghali C. A., Wright T. M. Ifn-. J. Immunol. 1995; 155: 3472–3480
   PubMed Web of Science ®Google Scholar
• Bergad P. L., Shih H. M., Towle H. C., Schwarzenberg S. J., Berry S. A. Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites. J. Biol. Chem. 1995; 270: 24903–24910
   PubMed Web of Science ®Google Scholar
• Shuai K., Liao J. Y., Song M. M. Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of stat1. Mol. Cell. Biol. 1996; 16: 4932–4941
   PubMed Web of Science ®Google Scholar
• Zhang J. J., Vinkemeier U., Gu W., Chakravarti D., Horvath C. M., Darnell J. E. Two contact regions between stat1 and cbp/p300 in interferon gamma signaling. Proc. Natl. Acad. Sci. USA 1996; 93: 15092–15096
   PubMed Web of Science ®Google Scholar
• Veals S. A., Schindler C., Leonard D., Fu X. Y., Aebersold R., Darnell J. E., Jr., Levy D. E. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell. Biol. 1992; 12: 3315–3324
   PubMed Web of Science ®Google Scholar
• Horvath C. M., Wen Z. L., Darnell J. E. A stat protein domain that determines dna sequence recognition suggests a novel dna-binding domain. Genes Dev. 1995; 9: 984–994
   PubMed Web of Science ®Google Scholar
• Bluyssen H. A., Muzaffar R., Vlieststra R. J., van M. A. C., Leung S., Stark G. R., Kerr I. M., Trapman J., Levy D. E. Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc. Natl. Acad. Sci. USA 1995; 92: 5645–5649
   PubMed Web of Science ®Google Scholar
• Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., Dandrea A., Livingston D. M. Cooperation of stat2 and p300/cbp in signalling induced by interferon-alpha. Nature 1996; 383: 344–347
   PubMed Web of Science ®Google Scholar
• Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 1997; 94: 3801–3804
   PubMed Web of Science ®Google Scholar
• Levy D. E., Lew D. J., Decker T., Kessler D. S., Darnell J. E., Jr. Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J. 1990; 9: 1105–1111
   PubMed Web of Science ®Google Scholar
• Decker T., Lew D. J., Cheng Y. S., Levy D. E., Darnell J. E., Jr. Interactions of alpha- and gamma-interferon in the transcriptional regulation of the gene encoding a guanylate-binding protein. EMBO J. 1989; 8: 2009–2014
   PubMed Web of Science ®Google Scholar
• Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N. A., Gilbert D. J., Copeland N. G., Hara T., Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 1995; 14: 2816–2826
   PubMed Web of Science ®Google Scholar
• Endo T. A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921–924
   PubMed Web of Science ®Google Scholar
• Starr R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J., Gonda T. J., Alexander W. S., Metcalf D., Nicola N. A., Hilton D. J. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917–921
   PubMed Web of Science ®Google Scholar
• Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387: 924–929
   PubMed Web of Science ®Google Scholar
• Chung C. D., Liao J., Liu B., Rao X., Jay P., Berta P., Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997; 278: 1803–1805
   PubMed Web of Science ®Google Scholar
• Reich N., Evans B., Levy D., Fahey D., Knight E. J., Darnell J. E., Jr. Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc. Natl. Acad. Sci. USA 1987; 84: 6394–6398
   PubMed Web of Science ®Google Scholar
• Levy D. E., Kessler D. S., Pine R., Reich N., Darnell J. E., Jr. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev. 1988; 2: 383–393
   PubMed Web of Science ®Google Scholar
• Lew D. J., Decker T., Strehlow I., Darnell J. E., Jr. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol. Cell. Biol. 1991; 11: 182–191
   PubMed Web of Science ®Google Scholar
• Jacobson N. G., Szabo S. J., Webernordt R. M., Zhong Z., Schreiber R. D., Darnell J. E., Murphy K. M. Interleukin 12 signaling in t helper type 1 (th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (stat)3 and stat4. J. Exp. Med. 1995; 181: 1755–1762
   PubMed Web of Science ®Google Scholar
• Seidel H. M., Milocco L. H., Lamb P., Darnell J. E., Jr., Stein R. B., Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA 1995; 92: 3041–3045
   PubMed Web of Science ®Google Scholar
• Gao J., Morrison D. C., Parmely T. J., Russell S. W., Murphy W. J. An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J. Biol. Chem. 1997; 272: 1226–1230
   PubMed Web of Science ®Google Scholar
• Caldenhoven E., Coffer P., Yuan J., Van de Stolpe A., Horn F., Kruijer W., Van der Saag P. T. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. J. Biol. Chem. 1994; 269: 21146–21154
   PubMed Web of Science ®Google Scholar
• Sims S. H., Cha Y., Romine M. F., Gao P. Q., Gottlieb K., Deisseroth A. B. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol. 1993; 13: 690–702
   PubMed Web of Science ®Google Scholar
• Pine R., Canova A., Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF- 1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J. 1994; 13: 158–167
   PubMed Web of Science ®Google Scholar
• Harada H., Takahashi E., Itoh S., Harada K., Hori T. A., Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol. 1994; 14: 1500–1509
   PubMed Web of Science ®Google Scholar
• Wright T. M., Farber J. M. 5' regulatory region of a novel cytokine gene mediates selective activation by interferon gamma. J. Exp. Med. 1991; 173: 417–422
   PubMed Web of Science ®Google Scholar
• Wong P., Severns C. W., Guyer N. B., Wright T. M. A unique palindromic element mediates gamma interferon induction of mig gene expression. Mol. Cell. Biol. 1994; 14: 914–922
   PubMed Web of Science ®Google Scholar
• Wegenka U. M., Buschmann J., Lutticken C., Heinrich P. C., Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 1993; 13: 276–288
   PubMed Web of Science ®Google Scholar
• Fujitani Y., Nakajima K., Kojima H., Nakae K., Takeda T., Hirano T. Transcriptional activation of the IL-6 response element in the junB promoter is mediated by multiple Stat family proteins. Biochem. Bioph. Res. Co. 1994; 202: 1181–1187
   PubMed Web of Science ®Google Scholar
• Coffer P., van Lutticken C. P. A., Klop-De J. M., Horn F., Kruijer W. Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction. Oncogene 1995; 10: 985–994
   PubMed Web of Science ®Google Scholar
• Zhang D. X., Sun M., Samols D., Kushner I. Stat3 participates in transcriptional activation of the c-reactive protein gene by interleukin-6. J. Biol. Chem. 1996; 271: 9503–9509
   PubMed Web of Science ®Google Scholar
• Bugno M., Graeve L., Gatsios P., Koj A., Heinrich P. C., Travis J., Kordula T. Identification of the interleukin-6 oncostatin m response element in the rat tissue inhibitor of metalloproteinases-1 (timp-1) promoter. Nucleic Acids Res. 1995; 23: 5041–5047
   PubMed Web of Science ®Google Scholar
• Korzus E., Nagase H., Rydell R., Travis J. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J. Biol. Chem. 1997; 272: 1188–1196
   PubMed Web of Science ®Google Scholar
• Yoshimura A., Ichihara M., Kinjyo I., Moriyama M., Copeland N. G., Gilbert D. J., Jenkins N. A., Hara T., Miyajima A. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 1996; 15: 1055–1063
   PubMed Web of Science ®Google Scholar
• Galsgaard E. D., Gouilleux F., Groner B., Serup P., Nielsen J. H., Billestrup N. Identification of a growth hormone-responsive stat5-binding element in the rat insulin 1 gene. Mol. Endocrinol. 1996; 10: 652–660
   PubMedGoogle Scholar
• Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H., Miyajima A., Yoshimura A. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997; 89: 3148–3154
   PubMed Web of Science ®Google Scholar
• Ascherman D. P., Migone T. S., Friedmann M. C., Leonard W. J. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation. J. Biol. Chem. 1997; 272: 8704–8709
   PubMedGoogle Scholar
• Delphin S., Stavnezer J. Characterization of an interleukin 4 (il-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter - regulation by nf-il-4, a c/ebp family member and nf-kappa-b p50. J. Exp. Med. 1995; 181: 181–192
   PubMed Web of Science ®Google Scholar
• Kotanides H., Reich N. C. Interleukin-4-induced stat6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. J. Biol. Chem. 1996; 271: 25555–25561
   PubMed Web of Science ®Google Scholar
• Lederer J. A., Perez V. L., Desroches L., Kim S. M., Abbas A. K., Lichtman A. H. Cytokine transcriptional events during helper t cell subset differentiation. J. Exp. Med. 1996; 184: 397–406
   PubMed Web of Science ®Google Scholar
• Curiel R. E., Lahesmaa R., Subleski J., Cippitelli M., Kirken R. A., Young H. A., Ghosh P. Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene. Eur. J. Immunol. 1997; 27: 1982–1987
   PubMed Web of Science ®Google Scholar
• Gouilleuxgruart V., Gouilleux F., Desaint C., Claisse J. F., Capiod J. C., Delobel J., Webernordt R., Dusanterfourt I., Dreyfus F., Groner B., Prin L. Stat-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 1996; 87: 1692–1697
   PubMed Web of Science ®Google Scholar
• Webernordt R. M., Egen C., Wehinger J., Ludwig W., Gouilleuxgruart V., Mertelsmann R., Finke J. Constitutive activation of stat proteins in primary lymphoid and myeloid leukemia cells and in epstein-barr virus (ebv)-related lymphoma cell lines. Blood 1996; 88: 809–816
   PubMed Web of Science ®Google Scholar
• Aronica M. G., Brizzi M. F., Dentelli P., Rosso A., Yarden Y., Pegoraro L. P91 Stat1 activation in interleukin-3-stimulated primary acute myeloid leukemia cells. Oncogene 1996; 13: 1017–1026
   PubMed Web of Science ®Google Scholar
• Shuai K., Halpern J., Tenhoeve J., Rao X. P., Sawyers C. L. Constitutive Activation of stat5 by the bcr-abl oncogene in chronic myelogenous leukemia. Oncogene 1996; 13: 247–254
   PubMed Web of Science ®Google Scholar
• Carlesso N., Frank D. A., Griffin J. D. Tyrosyl phosphorylation and dna binding activity of signal transducers and activators of transcription (stat) proteins in hematopoietic cell lines transformed by bcr/abl. J. Exp. Med. 1996; 183: 811–820
   PubMed Web of Science ®Google Scholar
• Frank D. A., Varticovski L. Bcr/Abl leads to the constitutive activation of stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia 1996; 10: 1724–1730
   PubMed Web of Science ®Google Scholar
• Ilaria R. L., Vanetten R. A. P210 and P190(Bcr/Abl) induce the tyrosine phosphorylation and dna binding activity of multiple specific stat family members. J. Biol. Chem. 1996; 271: 31704–31710
   PubMed Web of Science ®Google Scholar
• Frank D. A., Mahajan S., Ritz J. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J. Clin. Invest 1997; 100: 3140–3148
   PubMed Web of Science ®Google Scholar
• Zhang Q., Nowak I., Vonderheid E. C., Rook A. H., Kadin M. E., Nowell P. C., Shaw L. M., Wasik M. A. Activation of jak/stat proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant t lymphocytes derived from cutaneous anaplastic large t-cell lymphoma and sezary syndrome. Proc. Natl. Acad. Sci. USA 1996; 93: 9148–9153
   PubMed Web of Science ®Google Scholar
• Hoefsloot L. H., Van Amelsvoort M. P., Broeders L. C., van der Plas D. C., Van Lom K., Hoogerbrugge H., Touw I. P., Lowenberg B. Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome. Blood 1997; 89: 1690–1700
   PubMed Web of Science ®Google Scholar
• Nielsen M., Kaltoft K., Nordahl M., Ropke C., Geisler C., Mustelin T., Dobson P., Svejgaard A., Odum N. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc. Natl. Acad. Sci. USA 1997; 94: 6764–6769
   PubMed Web of Science ®Google Scholar
• Sartor C. I., Dziubinski M. L., Yu C. L., Jove R., Ethier S. P. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Research 1997; 57: 978–987
   PubMed Web of Science ®Google Scholar
• Su W. C., Kitagawa M., Xue N., Xie B., Garofalo S., Cho J., Deng C., Horton W. A., Fu X. Y. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 1997; 386: 288–292
   PubMed Web of Science ®Google Scholar